Skip to main content
logo
Vicore Pharma Holding AB (publ) (VCRE)
NASDAQ: VCRE · Real-Time Price · USD
11.28
+0.22 (1.99%)
Jul 28, 2026, 4:00 PM EDT - Market closed

Vicore Pharma Holding AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.533.82109.35000
Revenue Growth
-41.17%-96.51%----
Gross Profit
3.533.82109.35000
Operating Income
-484.69-452.39-194.19-321.51-290.73-294.82
Net Income
-474.56-477.47-168.63-310.94-288.42-296.48
Earnings Per Share
-1.90-1.99-1.23-3.18-3.99-4.25
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,0601,1671,156482.77261.74371.48
Total Debt
000000
Net Cash (Debt)
1,0601,1671,156482.77261.74371.48
Net Cash Growth
1.05%0.93%139.45%84.44%-29.54%0%
Net Cash Per Share
4.214.868.455.003.625.33

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-407.27-375.74-164.95-249.58-299.92-265.17
Free Cash Flow
-407.27-375.74-164.95-249.58-299.92-265.17
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%---
Operating Margin
-13742.20%-11851.90%-177.59%---
Pretax Margin
-13452.48%-12509.14%-154.45%---
Profit Margin
-13454.90%-12509.10%-154.22%---
FCF Margin
-11547.10%-9843.78%-150.85%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
868.127666.26199.93---